The Prognostic Value of Human Papilloma Virus in Nasopharyngeal Carcinoma

Overview

It is well established that HPV infection has a casual and is a prognostic factor in several cancer types, including oropharynx. We wish to examine if HPV infection has a prognostic significance in nasopharyngeal carcinoma.

Study Type

• Study Type: Observational
• Study Design
  • Time Perspective: Retrospective
• Study Primary Completion Date: July 2020

Clinical Trial Outcome Measures

Primary Measures

• Overall survival
  • Time Frame: 6 months

Participating in This Clinical Trial

Inclusion Criteria

• nasopharyngeal carcinoma patients treated in our institute between 2008-2018

Exclusion Criteria

• missing clinical data
• 2nd Head and neck primary cancer
• very locally advanced or distant metastatic nasopharyngeal carcinoma
• Prior radiation therapy to the head and neck region

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

• Lead Sponsor
  • Rambam Health Care Campus
• Provider of Information About this Clinical Study
  • Sponsor
• Overall Official(s)
  • Eran S Fridman, MD, Principal Investigator, Rambam Health Care Campus
• Overall Contact(s)
  • Eran S Fridman, MD, +972-4-7772480, eran.frid@gmail.com